(NXTM), a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. This stock is trading up 8.4% at $12.26 in Tuesday's trading session.
Tuesday's Volume: 1.02 million
Three-Month Average Volume: 543,708
Volume % Change: 201%
>>5 Stocks Insiders Love Right Now
From a technical perspective, NXTM is soaring higher here with above-average volume. This stock has been uptrending strong over the last month and change, with shares moving higher from its low of $8.77 to its intraday high of $12.40. During that uptrend, shares of NXTM have been making mostly higher lows and higher highs, which is bullish technical price action.
Traders should now look for long-biased trades in NXTM as long as it's trending above Tuesday's low of $11.55 and then once it sustains a move or close above its 200-day moving average of $12.30 with volume that's near or above 543,708 shares. If we get that move soon, then NXTM will set up to re-test or possibly take out its next major overhead resistance levels at $13.50 to $14. Any high-volume move above those levels will then give NXTM a chance to tag its 52-week high at $14.64 to $16.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts